Open Targets

Open Targets is an innovative, large-scale, multi-year, public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritisation.
Open Targets 是一项创新的、大规模的、多年期的公私合作伙伴关系，它使用人类遗传学和基因组学数据进行系统的药物靶标识别和优先排序。

Visit the Open Targets Platform which integrates public domain data to enable target identification and prioritisation, or the Open Targets Genetics portal which identifies targets based on GWAS and functional genomics. We complement data integration with large scale systematic experimental approaches to support target identification, prioritisation and validation. Check out our latest papers describing our experimental target identification approaches in oncology, neurodegeneration, and immunity and inflammation.
访问集成公共领域数据以实现目标识别和优先排序的 Open Targets 平台，或访问基于 GWAS 和功能基因组学识别目标的 Open Targets Genetics 门户。我们通过大规模系统实验方法补充数据集成，以支持目标识别、优先排序和验证。查看我们最新的论文，介绍我们在肿瘤学、神经变性以及免疫和炎症方面的实验性目标识别方法。